Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 1.031,32 €, with a 24-hour trading volume of 9,46M €. The asset's market cap is 919,67B €, after moving 0.91% in the last day.
Tokenized Eli Lilly And Co is trading at 1.036,59 €, with a tokenized market cap of 40,19M € and a 24-hour trading volume of 2,01M €. The tokenized asset has moved 2.18% in the past 24 hours.